Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting :

Information
Discussion (0)
Usage statistics

Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting : PROTEC - Berger, Thomas (Universitätsklinik für Neurologie) ; Brochet, B. (Groupe Hospitalier Pellegrin Hôpital Pellegrin) ; Brambilla, L. (IRCCS Foundation Neurological Institute Carlo Besta) ; Giacomini, P.S. (Montreal Neurological Institute Hospital) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Vasco Salgado, A (Hospital Professor Doutor Fernando Fonseca) ; Su, R (Biogen, USA) ; Bretagne, A (Biogen International GmbH) ; Universitat Autònoma de Barcelona. Departament de Medicina

Comments (0) | Reviews (0)

Be the first to review this document.

Add review

Rate this article:

Give a title to your review:

Write your review:

Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.

Similar records